- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Radiopharm Theranostics Ltd ADR (RADX)
Radiopharm Theranostics Ltd ADR stock price live, this page displays NASDAQ RADX stock exchange data. View the RADX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Radiopharm Theranostics Ltd ADR real time stock price chart below.
What Is the Radiopharm Theranostics Ltd ADR Stock Price Today?
The Radiopharm Theranostics Ltd ADR stock price today is 2.45.
What Is the Stock Symbol for Radiopharm Theranostics Ltd ADR?
The stock ticker symbol for Radiopharm Theranostics Ltd ADR is RADX.
Is RADX the Same as $RADX?
$RADX is a common way to refer to the Radiopharm Theranostics Ltd ADR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Radiopharm Theranostics Ltd ADR Trade On?
Radiopharm Theranostics Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Radiopharm Theranostics Ltd ADR a Good Stock to Buy?
Determining whether Radiopharm Theranostics Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Radiopharm Theranostics Ltd ADR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RADX quote. (ISIN: US75041J1016)
What Is the Radiopharm Theranostics Ltd ADR Stock Price Today?
The Radiopharm Theranostics Ltd ADR stock price today is 2.45.
What Is the Stock Symbol for Radiopharm Theranostics Ltd ADR?
The stock ticker symbol for Radiopharm Theranostics Ltd ADR is RADX.
Is RADX the Same as $RADX?
$RADX is a common way to refer to the Radiopharm Theranostics Ltd ADR ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Radiopharm Theranostics Ltd ADR Trade On?
Radiopharm Theranostics Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Radiopharm Theranostics Ltd ADR a Good Stock to Buy?
Determining whether Radiopharm Theranostics Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Radiopharm Theranostics Ltd ADR share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RADX quote. (ISIN: US75041J1016)
2.45
+0.16(+6.99%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.30
2.52
52 wk Range
2.23
16.25
RADX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.302.52
52 wk Range
2.2316.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RADX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
17.42
Upside
+611.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.42
(+611.12% Upside)
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare RADX to Peers and Sector
Metrics to compare | RADX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRADXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −6.2x | −0.3x | |
PEG Ratio | −0.02 | −0.03 | 0.00 | |
Price / Book | 0.8x | 2.6x | 2.6x | |
Price / LTM Sales | 2.7x | 13.3x | 3.1x | |
Upside (Analyst Target) | - | 110.4% | 47.6% | |
Fair Value Upside | Unlock | 7.9% | 5.6% | Unlock |
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Radiopharm Theranostics ADR (RADX) Stock Price Today?
The Radiopharm Theranostics ADR stock price today is 2.45 USD.
What Stock Exchange Does Radiopharm Theranostics ADR Trade On?
Radiopharm Theranostics ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Radiopharm Theranostics ADR?
The stock symbol for Radiopharm Theranostics ADR is "RADX."
What Is the Radiopharm Theranostics ADR Market Cap?
As of today, Radiopharm Theranostics ADR market cap is 31.11M USD.
What Is Radiopharm Theranostics ADR's Earnings Per Share (TTM)?
The Radiopharm Theranostics ADR EPS (TTM) is -0.02.
When Is the Next Radiopharm Theranostics ADR Earnings Date?
Radiopharm Theranostics ADR will release its next earnings report on Sep 24, 2026.
From a Technical Analysis Perspective, Is RADX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Radiopharm Theranostics ADR Stock Split?
Radiopharm Theranostics ADR has split 0 times.
How Many Employees Does Radiopharm Theranostics ADR Have?
Radiopharm Theranostics ADR has 14 employees.
What is the current trading status of Radiopharm Theranostics ADR (RADX)?
As of Aug 21, 2026, Radiopharm Theranostics ADR (RADX) is trading at a price of 2.45 USD, with a previous close of 2.29 USD. The stock has fluctuated within a day range of 2.30 USD to 2.52 USD, while its 52-week range spans from 2.23 USD to 16.25 USD.
What Is Radiopharm Theranostics ADR (RADX) Price Target According to Analysts?
The average 12-month price target for Radiopharm Theranostics ADR is 17.42 USD, with a high estimate of 30.78659713 USD and a low estimate of 12.76202043 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +611.12% Upside potential.
What Is the RADX Premarket Price?
RADX's last pre-market stock price is 2.41 USD. The pre-market share volume is 270.00, and the stock has decreased by 0.12, or 5.24%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.